30 Under 30 2019: Healthcare

When 29-year-old Stanford biology Ph.D. Trevor Martin decided to start a company, that meant wanting to create diagnostic tests, not drugs. To do that, Martin happened upon one of the hottest technologies in biotech: an enzyme called CRISPR. Rather than using it as a method for genetic editing, new research from the lab of CRISPR co-discoverer Jennifer Doudna showed it was possible to use it as not only a pair of scissors, but as a genetic search engine.